PPT-Hormonal contraception in women with DM and Thyroid disease

Agung Dewanto Oct 2017 Hormonal influences in metabolism Estrogen and lipid metabolisms in normal women Hormonal contraception COC in normal women Insulin and low estrogen level diabetes and . Margaret Burnett MD, FRCSC. April 19, . 2012. Disclosure. Bayer is one of the sponsors of our annual resident retreat and has provided models for our simulation program. The views I express regarding IUCD use are my own, based on my interpretation of the scientific literature and may be at odds (or perhaps just “odd”) with the manufacturers’ product monographs . Jennifer Meyers. Certified Nurse Midwife. Mayo Clinic Health System. Breastfeeding and Contraception. Jennifer Meyers, CNM. Mayo Clinic Health System, La Crosse. No financial disclosures, brand names used only for clarification. Chapter 12. Learning Objectives. Contraception. Contraception in the US: The political battle. Methods of Contraception. Abortion. Perspectives on Abortion. Methods of Abortion. Contraception. Contraception in US: The Legal Battle. for Contraceptive Use, 2010. Division of Reproductive Health. Centers for Disease Control and Prevention. August 1, 2013. National Center for Chronic Disease Prevention and Health Promotion . Division of Reproductive Health. 2016 U.S. Medical Eligibility Criteria for Contraceptive Use. Division of Reproductive Health. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion . Contraception: Beyond the Barrier. OBJECTIVES: At the end of presentation the participants:. 1. Will be able identify different types of contraception and assess for efficacy.. 2. Will be able to explain the mechanism of action for the different forms of contraception.. . Live Session. Offered by the New Mexico Pharmacists Association. Disclosure. The parties involved in creation and development of the New Mexico Pharmacists Prescriptive Authority have nothing to disclose. in Job Corps . Sara Mackenzie, MD, MPH. At the end of this session, participants will be able to:. Identify individual factors contributing to high unintended pregnancy rates in U.S.. Identify most effective forms contraception. Family Planning . for Persons Living with HIV/AIDS . Nikole D. . Gettings, BS, RN, MSN, CNM, APN . Activity Planning Committee. Medical Review Committee. Donna Randolph, MD. , CHOICES Medical Director. s. ). Dispelling the myths. Learning Objectives. Participants will be able to:. Understand the indications and contraindications to IUD use. Describe the pros and cons of hormonal vs non-hormonal IUD use. Jafari. Headache Department, Iranian Center of Neurological Research, . Tehran . University of Medical Sciences, Tehran, Iran.. . Migraine is . 3 times more . prevalent in women than in . men by the age . Dr. Shannon BatesRelationships with commercial interests:: Leo Pharma and Pfizer CanadaLeo Pharma and Pfizer CanadaConsulting Fees: Salary support through an endowed chair funded, in part, by Eli Thi Malachie NSANZAMAHORO,MD . . OB-Gyn. CHUK. Outline. • Objectives. • Depo . medroxy. progesterone acetate (DMPA). • Combination oral contraceptives. • Progestin only oral contraceptives. Dispelling the myths. Participants will be able to:. Understand the indications and contraindications to IUD use. Describe the pros and cons of hormonal vs non-hormonal IUD use. Explain the role of higher efficacy, non-user dependent, contraceptive methods like the IUD in the prevention of unintended pregnancy .